Widdrol blocks 3T3-L1 preadipocytes growth and differentiation due to inhibition of mitotic clonal expansion

Journal of Microbiology and Biotechnology

Volumn 22, Issue 6, 2012, Pages 806-813

  Yun, Hee Jung ^a   Kim, Jeong Hwan ^a   Jeong, Hyun Young ^b   Ji, Hyang Hwa ^a   Nam, Soo Wan ^a,c   Lee, Eun Woo ^a,b,c   Kim, Byung Woo ^a,b,c   Kwon, Hyun Ju ^a,b,c  

^a Dong Eui University   (South Korea)

^b Done Eui Universitv   (South Korea)

^c Blue Bio Industry RIC   (South Korea)

Author keywords

3T3 L1 preadipocyte; Adipocyte differentiation; Anti obesity; Mitotic clonal expansion; Widdrol

Indexed keywords

ANTIOBESITY AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIN DEPENDENT KINASE INHIBITOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; WIDDROL;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; LIPID STORAGE; MITOSIS INHIBITION; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; ANIMALS; BENZOCYCLOHEPTENES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GROWTH INHIBITORS; MICE; MITOSIS;

EID: 84861327381     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1110.10039     Document Type: Article

References (32)

1. Bray, G. A. and L. A. Tartaglia. 2000. Medicinal strategies in the treatment of obesity. Nature 404: 672-677.
2. Caro, J. F., L. G. Dohm, W. J. Pories, and M. K. Sinha. 1989. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diab. Metab. Rev. 5: 665-689.
3. Cornelius, P., O. A. MacDougald, and M. D. Lane. 1994. Regulation of adipocyte development. Annu. Rev. Nutr. 14: 99-129.
4. Couillard, C., P. Mauriège, P. Imbeault, D. Prudhomme, A. Nadeau, A. Tremblay, et al. 2000. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int. J. Obes. Relat. Metab. Disord. 24: 782-788.
5. DeGregori, J. 2004. The Rb network. J. Cell Sci. 117: 3411-3413.
6. Fanner, S. R. 2006. Transcriptional control of adipocyte formation. Cell Metab. 4: 263-273.
7. Formiguera, X. and A. Cantón. 2004. Obesity: Epidemiology and clinical aspects. Best Pract. Res. Clin. Gastroenterol. 18: 1125-1146.
8. Furuyashiki, T., H. Nagayasu, Y. Aoki, H. Bessho, T. Hashimoto, K. Kanazawa, and H. Ashida. 2004. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem. 68: 2353-2359.
9. Gregoire, F. M., C. M. Smas, and H. S. Sul. 1998. Understanding adipocyte differentiation. Physiol. Rev. 78: 783-809.
10. Harbour, J. W. and D. C. Dean. 2000. Rb function in cell-cycle regulation and apoptosis. Nat. Cell Biol. 2: E65-E67.
11. Hemati, N., S. E. Ross, R. L. Erickson, G. E. Groblewski, and O. A. MacDougald. 1997. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/ EBPalpha) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J. Biol. Chem. 272: 25913-25919.
12. Hung, P. F., B. T. Wu, H. C. Chen, Y. H. Chen, C. L. Chen, M. H. Wu, et al. 2005. Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and CDK2 pathways. Am. J. Physiol. Cell Physiol. 288: C1094-C1108.
13. Jones, K. H. and J. A. Senft. 1985. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate - propidium iodine. J. Histochem. Cytochem 33: 77-79.
14. Kwon, H. J., Y. K. Hong, C. Park, Y. H. Choi, H. J. Yun, E. W. Lee, and B. W. Kim. 2010. Widdrol induces cell cycle arrest, associated with MCM down-regulation, in human colon adenocarcinoma cells. Cancer Lett. 290: 96-103.
15. Lee, C. K., J. M. Fang, and Y. S. Cheng. 1995. Norditerpenes from Juniperus chinensis. Phytochemistry 39: 391-394.
16. Lee, W. J., E. H. Koh, J. C. Won, M. S. Kim, J. Y. Park, and K. U. Lee. 2005. Obesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation. Int. J. Biochem. Cell Biol. 37: 2254-2259.
17. Mayer, M. A., C. Hocht, A. Puyo, and C. A. Taira. 2009. Recent advances in obesity pharmacotherapy. Curr Clin. Pharmacol. 4: 53-61.
18. Morrison, R. F. and S. R. Farmer. 1999. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18 (INK4c) and p21 (Waf1/Cip1), during adipogenesis. J. Biol. Chem. 274: 17088-17097.
19. Nakayama, T., S. Suzuki, H. Kudo, S. Sassa, M. Nomura, and S. Sakamoto. 2007. Effects of three Chinese herbal medicines on plasma and liver lipids in mice fed a high-fat diet. J. Ethnopharmacol. 109: 236-240.
20. Otto, T. C. and M. D. Lane. 2005. Adipose development: From stem cell to adipocyte. Crit. Rev. Biochem. Mol. Biol. 40: 229-242.
21. Park, M. Y., K. S. Lee, and M. K. Sung. 2005. Effects of dietary mulberry, Korea red ginseng, and banaba on glucose homeostasis in relation to PPAR-a, PPAR-γ and LPL mRNA expressions. Life Sci. 77: 3344-3354.
22. Roncari, D. A., D. C. Lau, and S. Kindler. 1981. Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism 30: 425-427.
23. Rosen, E. D. and B. M. Spiegelman. 2000. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16: 145-171.
24. Sherr, C. J. and J. M. Roberts. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13: 1501-1512.
25. Tafuri, S. R. 1996. Troglitazone enhances differentiation, basal glucose uptake, and Glutl protein levels in 3T3-L1 adipocytes. Endocrinology 137: 4706-4712.
26. Tang, Q. Q., T. C. Otto, and M. D. Lane. 2003. Mitotic clonal expansion: A synchronous process required for adipogenesis. Proc. Natl. Acad. Sci. USA 100: 44-49.
27. Tong, Q. and G. S. Hotamisligil. 2001. Molecular mechanisms of adipocyte differentiation. Rev. Endocr. Metab. Disord. 2: 349-355.
28. Visscher, T. L. and J. C. Seidell. 2001. The public health impact of obesity. Annu. Rev. Public Health 22: 355-375.
29. Wang, Y. W. and P. J. Jones. 2004. Conjugated linoleic acid and obesity control: Efficacy and mechanisms. Int. J. Obes. Relat. Metab. Disord. 28: 941-955.
30. Yarelis, O. N., S. S. Iraida, G. C. Isidro, and H. G Rosario. 2006. The antifungal activity of widdrol and its biotransformation by Colletotrichum gloeosporioides (penz.) Penz & Sacc. and Botrytis cinerea Pers.; Fr. J. Agric. Food Chem. 54: 7517-7521.
31. Yarelis, O. N., S. S. Iraida, G. C. Isidro, and H. G. Rosario. 2007. Sesquiterpenes from the wood of Juniperus lucayana. Phytochemistry 68: 2409-2414.
32. Yun, J. W. 2010. Possible anti-obesity therapeutics from nature - A review. Phytochemistry 71: 1625-1641.